心肌缺血负荷与糖尿病患者预后差异:REFINE SPECT 注册研究
基于多中心国际 REFINE SPECT 注册研究,对 20,418 例接受 SPECT 心肌灌注显像的患者,按倾向评分匹配 2,951 例糖尿病与 2,951 例非糖尿病患者。自动量化总灌注缺损(TPD)显示,TPD>0% 各水平糖尿病患者主要不良心血管事件(MACE)风险均更高;TPD>10% 时糖尿病患者的年化 MACE 率是非糖尿病者的两倍以上。
要点
- 糖尿病患者 TPD>0% 各水平 MACE 风险均高于非糖尿病者。
- TPD>10% 时糖尿病年化 MACE 率 9.4% vs 非糖尿病 3.9%。
- 糖尿病 TPD 0.5% 的 MACE 风险约等于非糖尿病 TPD 8%。
核心结论
- 对于 TPD>0% 的每个水平,糖尿病患者 MACE 风险均高于非糖尿病患者。
- 糖尿病伴极少量缺血(0%<TPD<1%)时 MACE 风险已显著高于 TPD=0% 的糖尿病患者。
- 糖尿病伴少量缺血者的 MACE 风险与非糖尿病伴显著缺血者相当。
研究设计与样本
- 多中心国际 REFINE SPECT 注册研究,纳入 20,418 例接受单光子发射计算机断层心肌灌注显像者。
- 按风险因素用倾向评分匹配 2,951 例糖尿病与 2,951 例非糖尿病患者。
- TPD 分为 0%、0%<TPD<1%、1%≤TPD<5%、5%≤TPD≤10%、TPD>10% 五类。
- MACE 定义为全因死亡、心肌梗死、不稳定心绞痛或晚期血运重建的复合终点。
主要发现
- TPD>10% 时,糖尿病年化 MACE 率 9.4(95%CI 6.7-11.6),非糖尿病 3.9(95%CI 2.8-5.6),P<0.001。
- 糖尿病 0%<TPD<1% 者较 TPD=0% 者 MACE 风险更高,风险比 2.05(95%CI 1.21-3.47),P=0.007。
- 糖尿病 TPD 0.5% 者与非糖尿病 TPD 8% 者 MACE 风险相似。
- TPD>0% 各水平糖尿病与非糖尿病间 MACE 风险交互作用 P<0.001。
关键数值与推荐
- TPD 分类阈值:0%、0%<TPD<1%、1%≤TPD<5%、5%≤TPD≤10%、TPD>10%。
- MACE 复合终点:全因死亡、心肌梗死、不稳定心绞痛或晚期血运重建。
- TPD>10% 时糖尿病年化 MACE 率 9.4(95%CI 6.7-11.6),非糖尿病 3.9(95%CI 2.8-5.6)。
- 糖尿病 0%<TPD<1% 者 MACE 风险比 2.05(95%CI 1.21-3.47),P=0.007。
临床怎么用
- 糖尿病患者即使 TPD 极低(0%<TPD<1%),也应视为 MACE 高风险并加强管理。
- 糖尿病 TPD 0.5% 者的风险相当于非糖尿病 TPD 8% 者,提示对糖尿病患者的缺血阈值应更严格。
- TPD>10% 的糖尿病患者年化 MACE 率接近 10%,需强化二级预防与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Prevalence and prognostic impact of cardiovascular disease differ between patients with or without diabetes. We aimed to explore differences in the prevalence and prognosis of myocardial ischemia by automated quantification of total perfusion deficit (TPD) among patients with and without diabetes. RESEARCH DESIGN AND METHODS: Of 20,418 individuals who underwent single-photon emission computed tomography myocardial perfusion imaging, 2,951 patients with diabetes were matched to 2,951 patients without diabetes based on risk factors using propensity score. TPD was categorized as TPD = 0%, 0% < TPD < 1%, 1% ≤ TPD < 5%, 5% ≤ TPD ≤ 10%, and TPD >10%. Major adverse cardiovascular events (MACE) were defined as a composite of all-cause mortality, myocardial infarction, unstable angina, or late revascularization. RESULTS: MACE risk was increased in patients with diabetes compared with patients without diabetes at each level of TPD above 0 (P < 0.001 for interaction). In patients with TPD >10%, patients with diabetes had greater than twice the MACE risk compared with patients without diabetes (annualized MACE rate 9.4 [95% CI 6.7-11.6] and 3.9 [95% CI 2.8-5.6], respectively, P < 0.001). Patients with diabetes with even very minimal TPD (0% < TPD < 1%) experienced a higher risk for MACE than those with 0% TPD (hazard ratio 2.05 [95% CI 1.21-3.47], P = 0.007). Patients with diabetes with a TPD of 0.5% had a similar MACE risk as patients without diabetes with a TPD of 8%. CONCLUSIONS: For every level of TPD >0%, even a very minimal deficit of 0% < TPD < 1%, the MACE risk was higher in the patients with diabetes compared with patients without diabetes. Patients with diabetes with minimal ischemia had comparable MACE risk as patients without diabetes with significant ischemia.
引用
- Han D, Rozanski A, Gransar H, et al. Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT Registry. Diabetes Care. 2019. PMID: 31776140. doi:10.2337/dc19-1360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。